estriol has been researched along with Sensitivity and Specificity in 98 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Estriol (E3) is produced by the placenta and is important for early pregnancy maintenance." | 7.85 | Is salivary estriol detectable in very early pregnancy? ( Ehlert, U; La Marca-Ghaemmaghami, P; Wingeier, M; Zimmermann, R, 2017) |
| "Elevated third trimester salivary estriol levels have been associated with preterm birth." | 7.80 | Correlation between spontaneous preterm birth and mid-trimester maternal serum estriol. ( Capurro, D; Dunsmoor-Su, R; Gravett, MG; McMahon, K; Olsen, RN, 2014) |
| "To assess the clinical value of low maternal serum unconjugated estriol (E3) level for diagnosing Smith-Lemli-Opitz syndrome and other fetal clinical conditions in pregnant members of a large health maintenance organization." | 7.72 | Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions. ( Krieger, R; Norem, C; O'Keefe, J; Schoen, E; To, TT; Walton, D, 2003) |
| "An HPLC method for the direct and simultaneous determination of estriol 3- and 16-glucuronides in pregnancy urine is described." | 7.69 | Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching high-performance liquid chromatography with fluorescence detection. ( Hirose, T; Iwata, T; Yamaguchi, M, 1997) |
| "To evaluate prospectively maternal serum screening with alpha-fetoprotein (AFP), hCG, and unconjugated estriol (uE3) as a screen for fetal Down syndrome." | 7.68 | Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. ( Andersen, RN; Elias, S; Morgan, CD; Phillips, OP; Shulman, LP; Simpson, JL, 1992) |
| "To test the efficacy of a screening protocol using a combination of maternal age plus three biochemical markers--maternal serum alpha-fetoprotein (MSAFP), hCG, and unconjugated estriol (E3)--for the antenatal detection of fetal Down syndrome." | 7.68 | A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. ( Cheng, EY; Hickok, DE; Lieppman, RE; Luthy, DA; Williams, MA; Zebelman, AM, 1993) |
| "Nuchal thickness was obtained prospectively in 651 consecutive fetuses at 14 to 21 weeks' gestation and at > or = 1:270 risk for Down syndrome on the basis of unconjugated estriol, alpha-fetoprotein, and human chorionic gonadotropin levels." | 5.08 | Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results. ( Bahado-Singh, RO; Baumgarten, A; Copel, JA; Goldstein, I; Mahoney, MJ; Uerpairojkit, B, 1995) |
| "Estriol (E3) is produced by the placenta and is important for early pregnancy maintenance." | 3.85 | Is salivary estriol detectable in very early pregnancy? ( Ehlert, U; La Marca-Ghaemmaghami, P; Wingeier, M; Zimmermann, R, 2017) |
| "To discover the value of combined maternal first and second-trimester serum β-hCG, pregnancy associated plasma protein A (PAPP-A), alpha-fetoprotein(AFP)and unconjugated estriol (uE3) in the prediction of preeclampsia." | 3.81 | [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia]. ( Gu, W; Hou, Y; Lin, J, 2015) |
| "Elevated third trimester salivary estriol levels have been associated with preterm birth." | 3.80 | Correlation between spontaneous preterm birth and mid-trimester maternal serum estriol. ( Capurro, D; Dunsmoor-Su, R; Gravett, MG; McMahon, K; Olsen, RN, 2014) |
| " Serum markers studied as possible predictors of early loss included first-trimester pregnancy-associated plasma protein A and second-trimester alpha-fetoprotein, and unconjugated estriol." | 3.74 | Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers. ( Belfort, MA; Carr, SR; Comstock, CH; Craigo, SD; Cuckle, HS; D'Alton, ME; Dar, P; Dugoff, L; Eddleman, KA; Hobbins, JC; Malone, FD; Nyberg, DA; Saade, GR; Timor-Tritsch, IE; Wolfe, HM, 2008) |
| " All patients had a first-trimester nuchal translucency scan, and those without cystic hygroma had a combined test (nuchal translucency, pregnancy-associated plasma protein A, and free beta-hCG) and returned at 15-18 weeks for a second-trimester quadruple screen (serum alpha-fetoprotein, total hCG, unconjugated estriol, and inhibin-A)." | 3.74 | First- and second-trimester screening: detection of aneuploidies other than Down syndrome. ( Berkowitz, RL; Bianchi, DW; Breathnach, FM; Carr, SR; Comstock, CH; Craigo, SD; Cuckle, HS; D'Alton, ME; Dugoff, L; Klugman, S; Lambert-Messerlian, G; Malone, FD; Nyberg, DA; Porter, TF; Saade, GR; Timor-Tritsch, IE; Tripp, T; Wolfe, HM, 2007) |
| " Those women with borderline Down syndrome risks received follow-up second-trimester maternal serum involving double, triple, or quadruple serum screening markers: alpha-fetoprotein, free beta-hCG or total hCG, unconjugated estriol and inhibin-A." | 3.73 | Practical strategies in contingent sequential screening for Down syndrome. ( Benn, P; Cuckle, H; Wright, D, 2005) |
| "The best combination of serum markers includes pregnancy-associated plasma protein-A in the first trimester and alpha-fetoprotein, unconjugated estriol and human chorionic gonadotropin in the second trimester." | 3.72 | Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers. ( Haddow, JE; Knight, GJ; Neveux, LM; Palomaki, GE, 2003) |
| "To evaluate the efficacy of the second-trimester quadruple test (maternal serum alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin, and inhibin-A) in prenatal screening for Down syndrome." | 3.72 | Incorporation of inhibin-A in second-trimester screening for Down syndrome. ( Benn, PA; Collins, R; Egan, JF; Fang, M; Horne, D, 2003) |
| "To assess the clinical value of low maternal serum unconjugated estriol (E3) level for diagnosing Smith-Lemli-Opitz syndrome and other fetal clinical conditions in pregnant members of a large health maintenance organization." | 3.72 | Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions. ( Krieger, R; Norem, C; O'Keefe, J; Schoen, E; To, TT; Walton, D, 2003) |
| " There is interesting to establish a noninvasive test for the early detection of fetal malformation in pregnancy which is based on ultrasound examination (NT measurement from the 10th to the 19th weeks, presence of nasal bone in the first trimester ultrasound), correlated with serum concentration of AFP, beta-HCG and oestriol in the second trimester of pregnancy (triple test)." | 3.72 | [Diagnostic methods for fetal malformations in the first half of pregnancy]. ( Baś-Budecka, E; Sieroszewski, P; Suzin, J, 2003) |
| "Maternal serum alpha-fetoprotein (MSAFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3) are used in combination with maternal age to calculate the risk for Down syndrome (DS) in pregnancy." | 3.70 | Fetal gender impact on multiple-marker screening results. ( Ayoub, M; Bazzett, LB; Critchfield, G; Evans, MI; Johnson, MP; Kramer, RL; O'Brien, JE; Yaron, Y, 1998) |
| "to review the contribution of unconjugated estriol in Down's syndrome detection, and influence of maternal age, cut-off choice, and population specificity on the balance between triple-marker test sensitivity and specificity." | 3.70 | The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity. ( Huderer-Duric, K; Kuvacic, I; Rubala, D; Skrablin, S; Sonicki, Z; Suchanek, E, 2000) |
| "Serum samples from 320 women with chromosomally normal fetuses and from 50 women with fetuses affected by Down's syndrome were assayed retrospectively for human chorionic gonadotropin (hCG), pregnancy-specific beta 1 glycoprotein (SP1), alpha fetoprotein (AFP), and unconjugated estriol (uE3) between 14 and 21 weeks of gestation." | 3.69 | Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers. ( Bartels, I; Bockel, B; Caesar, J; Krawczak, M; Rauskolb, R; Thiele, M, 1994) |
| "Data from 24,504 patients who had biochemical screening for Down syndrome by single (alpha-fetoprotein), double (alpha-fetoprotein, beta-human chorionic gonadotropin), or triple screening (alpha-fetoprotein, beta-human chorionic gonadotropin, unconjugated estriol) who had complete outcome information were analyzed by (1) existing gaussian-based methods, (2) the Glasgow ratio method, and (3) a new statistical approach (i." | 3.69 | MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs. ( Ager, JW; Ayoub, M; Chik, L; Chin, B; Dvorin, E; Evans, MI; Johnson, MP; Krivchenia, EL; O'Brien, JE; Sokol, RJ, 1995) |
| "There were no significant correlations between birthweight ratio (ratio of birthweight to mean weight for gestational age) and hCG, but between birthweight ratio on one hand and estriol for all stages of pregnancy (r = 0." | 3.69 | Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. ( Aakvaag, A; Bakketeig, LS; Bergsjø, P; Hoffman, HJ; Jacobsen, G; Lie, RT; Markestad, T, 1997) |
| "An HPLC method for the direct and simultaneous determination of estriol 3- and 16-glucuronides in pregnancy urine is described." | 3.69 | Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching high-performance liquid chromatography with fluorescence detection. ( Hirose, T; Iwata, T; Yamaguchi, M, 1997) |
| " Along with information about the pregnancy, we obtained a serum sample for measurement of alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin." | 3.69 | Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. ( Boyd, PA; Cunningham, GC; Haddow, JE; Knight, GJ; Lustig, LS; Palomaki, GE, 1994) |
| "To test the efficacy of a screening protocol using a combination of maternal age plus three biochemical markers--maternal serum alpha-fetoprotein (MSAFP), hCG, and unconjugated estriol (E3)--for the antenatal detection of fetal Down syndrome." | 3.68 | A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. ( Cheng, EY; Hickok, DE; Lieppman, RE; Luthy, DA; Williams, MA; Zebelman, AM, 1993) |
| "Information on maternal age and maternal serum alpha-fetoprotein, unconjugated oestriol (uE3), and human chorionic gonadotrophin (hCG) levels was used to investigate retrospectively the effect of estimating Edward's syndrome risk in women having multi-marker screening for Down's syndrome." | 3.68 | Expanding multiple marker screening for Down's syndrome to include Edward's syndrome. ( Barkai, G; Chaki, R; Cuckle, H; Goldman, B; Ries, L; Zer, T, 1993) |
| "To evaluate prospectively maternal serum screening with alpha-fetoprotein (AFP), hCG, and unconjugated estriol (uE3) as a screen for fetal Down syndrome." | 3.68 | Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. ( Andersen, RN; Elias, S; Morgan, CD; Phillips, OP; Shulman, LP; Simpson, JL, 1992) |
| "The risk of fetal trisomy 21 was calculated with the use of PRISCA 3." | 2.69 | Analysis of triple test results in 27 cases of twin pregnancies. ( Dudarewicz, L; Kałuzewski, B; Perenc, M, 1998) |
| "Having a baby with Down's syndrome is likely to have a significant impact on family life." | 2.52 | Urine tests for Down's syndrome screening. ( Alfirevic, Z; Alldred, SK; Deeks, JJ; Guo, B; Neilson, JP; Pennant, M; Takwoingi, Y; Wisniewski, S, 2015) |
| "Down syndrome (trisomy 21) is the most commonly recognized genetic cause of mental retardation." | 2.41 | Down syndrome: prenatal risk assessment and diagnosis. ( Newberger, DS, 2000) |
| "In five studies the rate of vaginal bleeding in Down's syndrome pregnancies was 1." | 2.39 | Taking account of vaginal bleeding in screening for Down's syndrome. ( Cuckle, H; Holding, S; Mason, G; van Oudgaarden, ED, 1994) |
| "Estriol was administered for 5 weeks: the first week one vaginal suppository every evening, the other four weeks the administration was twice a week." | 1.51 | Management of ASC-US/HPV positive post-menopausal woman. ( Bonanno, G; Bruno, MT; Coco, A; Di Pasqua, S, 2019) |
| "In the first trimester fetal malformations are associated with high values for fetal NT." | 1.32 | [Combination of screening tests for fetal abnormalities in the first and second pregnancy trimesters]. ( Baś-Budecka, E; Sieroszewski, P; Suzin, J, 2004) |
| "In women who presented with symptomatic preterm labor, salivary E3 identified 61% of those who delivered within 2 weeks, using a threshold of 1." | 1.31 | Serial salivary estriol to detect an increased risk of preterm birth. ( Artal, R; Goodwin, TM; Hayashi, RH; Heine, RP; McGregor, JA; Robertson, PA; Varner, MW, 2000) |
| "However, approximately 6-10% of trisomy 18 affected pregnancies will be screen-positive for Down syndrome but screen-negative for trisomy 18." | 1.31 | Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. ( Beazoglou, T; Benn, PA; Egan, JF; Ying, J, 2001) |
| "Three non-Down syndrome chromosomal abnormalities and two Down syndrome mosaic cases would be missed by this approach." | 1.31 | A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%. ( Amiel, A; Ben-Tovim, T; Fejgin, MD; Kaneti, H; Kedar, I; Petel, Y; Rosen, DJ; Tohar, M, 2002) |
| "To determine if a false-positive trisomy 18 multiple-marker screening test (all three analytes low: maternal serum alpha-fetoprotein [AFP] at most 0." | 1.30 | Significance of a false-positive trisomy 18 multiple-marker screening test. ( Brumfield, CG; Davis, RO; Dubard, M; Garcia, T; Owen, J; Wenstrom, KD, 1997) |
| "Since most fetuses with trisomy 18 exhibit morphological abnormalities which should be detected following a careful ultrasonographic examination, biochemical screening could help in the detection of those anatomical defects in selecting for scanning a group of high risk women." | 1.29 | The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18. ( Herlicoviez, M; Herrou, M; Leporrier, N; Leymarie, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (3.06) | 18.7374 |
| 1990's | 41 (41.84) | 18.2507 |
| 2000's | 40 (40.82) | 29.6817 |
| 2010's | 12 (12.24) | 24.3611 |
| 2020's | 2 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Li, L | 1 |
| Bian, Y | 1 |
| Yu, Y | 1 |
| Qiang, Z | 2 |
| Zhang, Y | 1 |
| Li, H | 1 |
| Amini, M | 1 |
| Kazemnejad, A | 1 |
| Zayeri, F | 1 |
| Montazeri, A | 1 |
| Rasekhi, A | 1 |
| Amirian, A | 1 |
| Kariman, N | 1 |
| Quibel, T | 1 |
| Rozenberg, P | 2 |
| Wanapirak, C | 1 |
| Piyamomgkol, W | 1 |
| Sirichotiyakul, S | 1 |
| Tongprasert, F | 1 |
| Srisupundit, K | 1 |
| Luewan, S | 1 |
| Traisrisilp, K | 1 |
| Jatavan, P | 1 |
| Tongsong, T | 1 |
| Bruno, MT | 1 |
| Coco, A | 1 |
| Di Pasqua, S | 1 |
| Bonanno, G | 1 |
| Olsen, RN | 1 |
| Dunsmoor-Su, R | 1 |
| Capurro, D | 1 |
| McMahon, K | 1 |
| Gravett, MG | 1 |
| Gu, W | 1 |
| Lin, J | 1 |
| Hou, Y | 1 |
| Zhao, F | 1 |
| Chai, D | 1 |
| Lu, J | 1 |
| Yu, J | 1 |
| Liu, S | 1 |
| Alldred, SK | 2 |
| Guo, B | 2 |
| Takwoingi, Y | 2 |
| Pennant, M | 2 |
| Wisniewski, S | 1 |
| Deeks, JJ | 2 |
| Neilson, JP | 2 |
| Alfirevic, Z | 2 |
| Wingeier, M | 1 |
| La Marca-Ghaemmaghami, P | 1 |
| Zimmermann, R | 1 |
| Ehlert, U | 1 |
| Dugoff, L | 2 |
| Cuckle, HS | 3 |
| Hobbins, JC | 1 |
| Malone, FD | 2 |
| Belfort, MA | 1 |
| Nyberg, DA | 2 |
| Comstock, CH | 2 |
| Saade, GR | 2 |
| Eddleman, KA | 1 |
| Dar, P | 1 |
| Craigo, SD | 2 |
| Timor-Tritsch, IE | 2 |
| Carr, SR | 2 |
| Wolfe, HM | 2 |
| D'Alton, ME | 2 |
| Salazar López, R | 1 |
| Ibarra Gallardo, AL | 1 |
| Iduma Meléndrez, M | 1 |
| Leyva Bojórquez, R | 1 |
| Jelliffe-Pawlowski, LL | 1 |
| Walton-Haynes, L | 1 |
| Currier, RJ | 1 |
| Lachelin, GC | 2 |
| McGarrigle, HH | 1 |
| Seed, PT | 1 |
| Briley, A | 1 |
| Shennan, AH | 1 |
| Poston, L | 1 |
| Montsko, G | 1 |
| Vaczy, A | 1 |
| Maasz, G | 1 |
| Mernyak, E | 1 |
| Frank, E | 1 |
| Bay, C | 1 |
| Kadar, Z | 1 |
| Ohmacht, R | 1 |
| Wolfling, J | 1 |
| Mark, L | 1 |
| Nie, Y | 1 |
| Zhang, H | 1 |
| Adams, C | 1 |
| Del Carmen Saucedo, M | 1 |
| DeVigan, C | 1 |
| Vodovar, V | 1 |
| Lelong, N | 1 |
| Goffinet, F | 1 |
| Khoshnood, B | 1 |
| Caron, E | 1 |
| Sheedy, C | 1 |
| Farenhorst, A | 1 |
| Torricelli, M | 1 |
| Novembri, R | 1 |
| Voltolini, C | 1 |
| Conti, N | 1 |
| Biliotti, G | 1 |
| Piccolini, E | 1 |
| Cevenini, G | 1 |
| Smith, R | 1 |
| Petraglia, F | 1 |
| Wang, S | 1 |
| Li, Y | 1 |
| Ding, M | 1 |
| Wu, X | 1 |
| Xu, J | 1 |
| Wang, R | 1 |
| Wen, T | 1 |
| Huang, W | 1 |
| Zhou, P | 1 |
| Ma, K | 1 |
| Zhou, X | 1 |
| Du, S | 1 |
| Benijts, T | 1 |
| Dams, R | 1 |
| Günther, W | 1 |
| Lambert, W | 1 |
| Leenheer, AD | 1 |
| Azuma, M | 1 |
| Yamamoto, R | 1 |
| Wakui, Y | 1 |
| Minobe, S | 1 |
| Satomura, S | 1 |
| Fujimoto, S | 1 |
| Majima, K | 1 |
| Fukui, T | 1 |
| Yuan, J | 2 |
| Wang, G | 1 |
| Matsumoto, K | 1 |
| Benn, PA | 3 |
| Kaminsky, LM | 1 |
| Ying, J | 2 |
| Borgida, AF | 1 |
| Egan, JF | 3 |
| Ohmura, N | 2 |
| Tsukidate, Y | 1 |
| Shinozaki, H | 1 |
| Lackie, SJ | 2 |
| Saiki, H | 2 |
| Palomaki, GE | 3 |
| Neveux, LM | 1 |
| Knight, GJ | 3 |
| Haddow, JE | 3 |
| Fang, M | 1 |
| Horne, D | 1 |
| Collins, R | 1 |
| Schoen, E | 1 |
| Norem, C | 1 |
| O'Keefe, J | 1 |
| Krieger, R | 1 |
| Walton, D | 1 |
| To, TT | 1 |
| BARLOW, JJ | 1 |
| Sieroszewski, P | 2 |
| Suzin, J | 2 |
| Baś-Budecka, E | 2 |
| Guo, T | 1 |
| Chan, M | 1 |
| Soldin, SJ | 1 |
| Ilagan, JG | 1 |
| Stamilio, DM | 2 |
| Ural, SH | 1 |
| Macones, GA | 2 |
| Odibo, AO | 2 |
| Rourke, JE | 1 |
| Marshall, LD | 1 |
| Shelley, TF | 1 |
| Jiang, JP | 1 |
| Du, M | 1 |
| Huang, XY | 1 |
| Benn, P | 1 |
| Wright, D | 1 |
| Cuckle, H | 3 |
| Yeast, JD | 1 |
| Lu, G | 1 |
| Husseini, A | 1 |
| Akkawi, M | 1 |
| Sehdev, HM | 1 |
| Sayin, NC | 1 |
| Canda, MT | 1 |
| Ahmet, N | 1 |
| Arda, S | 1 |
| Süt, N | 1 |
| Varol, FG | 1 |
| Breathnach, FM | 1 |
| Lambert-Messerlian, G | 1 |
| Porter, TF | 1 |
| Berkowitz, RL | 1 |
| Klugman, S | 1 |
| Tripp, T | 1 |
| Bianchi, DW | 1 |
| Sluss, PM | 1 |
| Hayes, FJ | 1 |
| Adams, JM | 1 |
| Barnes, W | 1 |
| Williams, G | 1 |
| Frost, S | 1 |
| Ramp, J | 1 |
| Pacenti, D | 1 |
| Lehotay, DC | 1 |
| George, S | 1 |
| Ramsay, C | 1 |
| Doss, RC | 1 |
| Crowley, WF | 1 |
| Lamlertkittikul, S | 1 |
| Chandeying, V | 1 |
| Shi, YQ | 1 |
| Yao, J | 1 |
| Liu, F | 1 |
| Hu, CQ | 1 |
| Zhang, QM | 1 |
| Jin, SH | 1 |
| Bahado-Singh, RO | 3 |
| Goldstein, I | 1 |
| Uerpairojkit, B | 1 |
| Copel, JA | 1 |
| Mahoney, MJ | 5 |
| Baumgarten, A | 3 |
| McGregor, JA | 2 |
| Jackson, GM | 1 |
| Goodwin, TM | 2 |
| Artal, R | 2 |
| Hastings, C | 1 |
| Dullien, V | 1 |
| Barkai, G | 1 |
| Goldman, B | 1 |
| Ries, L | 1 |
| Chaki, R | 1 |
| Zer, T | 1 |
| Cunningham, GC | 1 |
| Lustig, LS | 1 |
| Boyd, PA | 2 |
| Bartels, I | 1 |
| Bockel, B | 1 |
| Caesar, J | 1 |
| Krawczak, M | 1 |
| Thiele, M | 1 |
| Rauskolb, R | 1 |
| Aymé, S | 1 |
| Aurran, Y | 1 |
| Chabal, F | 1 |
| Gombert, A | 1 |
| Loundou, H | 1 |
| Montfort, C | 1 |
| Sollier, M | 1 |
| Silvestri, A | 1 |
| van Oudgaarden, ED | 1 |
| Mason, G | 1 |
| Holding, S | 1 |
| Kellner, LH | 1 |
| Weiss, RR | 1 |
| Weiner, Z | 1 |
| Neuer, M | 1 |
| Martin, GM | 1 |
| Schulman, H | 1 |
| Lipper, S | 1 |
| Evans, MI | 3 |
| Chik, L | 1 |
| O'Brien, JE | 3 |
| Chin, B | 1 |
| Dvorin, E | 1 |
| Ayoub, M | 2 |
| Krivchenia, EL | 1 |
| Ager, JW | 1 |
| Johnson, MP | 2 |
| Sokol, RJ | 1 |
| Arabin, B | 1 |
| Ragosch, V | 1 |
| Mohnhaupt, A | 1 |
| Cheng, EY | 1 |
| Luthy, DA | 1 |
| Zebelman, AM | 1 |
| Williams, MA | 1 |
| Lieppman, RE | 1 |
| Hickok, DE | 1 |
| Hecher, K | 1 |
| Snijders, R | 1 |
| Nicolaides, K | 1 |
| Pescia, G | 1 |
| Dao, MH | 1 |
| Weihs, D | 1 |
| Gaide, AC | 1 |
| Loertscher, A | 1 |
| Hohlfeld, P | 1 |
| Marguerat, P | 1 |
| Nguyen The, H | 1 |
| Paccaud, F | 1 |
| Maillard, C | 1 |
| Shackley, P | 1 |
| McGuire, A | 1 |
| Dennis, J | 1 |
| Fitchett, M | 1 |
| Kay, J | 1 |
| Roche, M | 1 |
| Wood, P | 1 |
| Leporrier, N | 1 |
| Herrou, M | 1 |
| Herlicoviez, M | 1 |
| Leymarie, P | 1 |
| Chard, T | 1 |
| Piggott, M | 1 |
| Wilkinson, P | 1 |
| Bennett, J | 1 |
| Wilkins-Haug, L | 1 |
| Horton, JA | 1 |
| Cruess, DF | 1 |
| Frigoletto, FD | 1 |
| Podestà, A | 1 |
| Smith, CJ | 1 |
| Villani, C | 1 |
| Montagnoli, G | 1 |
| Sato, H | 1 |
| Mochizuki, H | 1 |
| Tomita, Y | 1 |
| Kanamori, T | 1 |
| Markestad, T | 1 |
| Bergsjø, P | 1 |
| Aakvaag, A | 1 |
| Lie, RT | 1 |
| Jacobsen, G | 1 |
| Hoffman, HJ | 1 |
| Bakketeig, LS | 1 |
| Iwata, T | 1 |
| Hirose, T | 1 |
| Yamaguchi, M | 1 |
| Wenstrom, KD | 1 |
| Owen, J | 1 |
| Brumfield, CG | 1 |
| Davis, RO | 1 |
| Dubard, M | 1 |
| Garcia, T | 1 |
| Bazzett, LB | 1 |
| Yaron, Y | 1 |
| Critchfield, G | 1 |
| Kramer, RL | 1 |
| Tanaka, T | 2 |
| Yanagi, M | 1 |
| Kubodera, A | 1 |
| Oz, AU | 1 |
| Kovanci, E | 2 |
| Deren, O | 1 |
| Copel, J | 2 |
| Mahoney, J | 1 |
| Bahado-Singh, R | 3 |
| Oz, U | 2 |
| Cermik, D | 1 |
| Cole, L | 3 |
| Tagawa, N | 1 |
| Tsuruta, H | 1 |
| Fujinami, A | 1 |
| Kobayashi, Y | 1 |
| Cole, LA | 1 |
| Rinne, KM | 1 |
| Mahajan, SM | 1 |
| Oz, UA | 2 |
| Shahabi, S | 2 |
| Wald, NJ | 3 |
| Watt, HC | 1 |
| Hackshaw, AK | 2 |
| Rinne, K | 1 |
| Hunter, D | 1 |
| Ognibene, A | 1 |
| Ciuti, R | 1 |
| Tozzi, P | 1 |
| Messeri, G | 1 |
| Huderer-Duric, K | 1 |
| Skrablin, S | 1 |
| Kuvacic, I | 1 |
| Sonicki, Z | 1 |
| Rubala, D | 1 |
| Suchanek, E | 1 |
| Perenc, M | 1 |
| Dudarewicz, L | 1 |
| Kałuzewski, B | 1 |
| Newberger, DS | 1 |
| Heine, RP | 1 |
| Hayashi, RH | 1 |
| Robertson, PA | 1 |
| Varner, MW | 1 |
| Xiao, X | 1 |
| McCalley, D | 1 |
| Onda, T | 1 |
| Yoshida, K | 1 |
| Nakamura, Y | 1 |
| Kudo, R | 1 |
| Yamamoto, H | 1 |
| Sato, A | 1 |
| Yanagida, K | 1 |
| Takai, Y | 1 |
| Uemura, H | 1 |
| Hoshi, K | 1 |
| Fukada, Y | 1 |
| Miyake, Y | 1 |
| Ohnishi, M | 1 |
| Kaneoka, T | 1 |
| Makino, Y | 1 |
| Murata, Y | 1 |
| Kanzaki, T | 1 |
| Kanzaki, H | 1 |
| Osaki, T | 1 |
| Aono, T | 1 |
| Maeda, K | 1 |
| Ogita, S | 1 |
| Yamamasu, S | 1 |
| Aso, T | 1 |
| Shimizu, Y | 2 |
| Izutsu, T | 1 |
| Kudo, T | 1 |
| Okai, T | 1 |
| Sakai, M | 1 |
| Hashimoto, T | 1 |
| Matsuzaki, N | 1 |
| Kitagawa, M | 1 |
| Sago, H | 1 |
| Grier, RE | 1 |
| Myrick, F | 1 |
| Beazoglou, T | 1 |
| Senat, MV | 1 |
| Bernard, JP | 1 |
| Ville, Y | 1 |
| Rosen, DJ | 1 |
| Kedar, I | 1 |
| Amiel, A | 1 |
| Ben-Tovim, T | 1 |
| Petel, Y | 1 |
| Kaneti, H | 1 |
| Tohar, M | 1 |
| Fejgin, MD | 1 |
| Karaca, M | 1 |
| Verloes, A | 1 |
| Schoos, R | 1 |
| Koulischer, L | 1 |
| Williams, J | 1 |
| Pulkkinen, A | 1 |
| Canick, JA | 1 |
| Saller, DN | 1 |
| Bowers, GB | 1 |
| Phillips, OP | 1 |
| Elias, S | 1 |
| Shulman, LP | 1 |
| Andersen, RN | 1 |
| Morgan, CD | 1 |
| Simpson, JL | 1 |
| Drugan, A | 1 |
| Gambino, RS | 1 |
| Fujii, Y | 1 |
| Teranishi, M | 1 |
| Nakada, K | 1 |
| Yamazaki, M | 1 |
| Kishida, S | 1 |
| Miyabo, S | 1 |
| MacDonald, ML | 1 |
| Wagner, RM | 1 |
| Slotnick, RN | 1 |
| Macri, JN | 1 |
| Kasturi, RV | 1 |
| Krantz, DA | 1 |
| Cook, EJ | 1 |
| Kim, MH | 1 |
| Gumpel, JA | 1 |
| Cleary, RE | 1 |
9 reviews available for estriol and Sensitivity and Specificity
| Article | Year |
|---|---|
Urine tests for Down's syndrome screening.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol; False Positive React | 2015 |
First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol; False Positive React | 2017 |
Biochemical markers for the prediction of preterm labor.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Corticotropin-Releasing | 2005 |
Taking account of vaginal bleeding in screening for Down's syndrome.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Humans; Pregnancy | 1994 |
Screening for fetal chromosomal abnormalities by maternal serum biochemistry and ultrasound examination of fetal morphology.
Topics: alpha-Fetoproteins; Antigens, Tumor-Associated, Carbohydrate; Biomarkers; Chorionic Gonadotropin; Ch | 1993 |
Down syndrome: prenatal risk assessment and diagnosis.
Topics: Algorithms; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chorionic Villi S | 2000 |
[Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
Topics: Algorithms; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Decision Tr | 2001 |
Prenatal biochemical screening.
Topics: alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Congenital Abnormalities; Estriol; Female | 1992 |
Biochemical screening.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Genetic Testing; Humans; | 1990 |
3 trials available for estriol and Sensitivity and Specificity
| Article | Year |
|---|---|
Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Hu | 1995 |
Salivary estriol as risk assessment for preterm labor: a prospective trial.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Estriol; False Positive Reactions; Female; Hum | 1995 |
Analysis of triple test results in 27 cases of twin pregnancies.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Gestational Age; Humans; | 1998 |
86 other studies available for estriol and Sensitivity and Specificity
| Article | Year |
|---|---|
Quantitation of estradiol by competitive light-initiated chemiluminescent assay using estriol as competitive antigen.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antigens; Bilirubin; Biotinylation; Calibration; Es | 2020 |
Diagnostic accuracy of maternal serum multiple marker screening for early detection of gestational diabetes mellitus in the absence of a gold standard test.
Topics: Adult; alpha-Fetoproteins; Bayes Theorem; Biomarkers; Chorionic Gonadotropin; Chorionic Gonadotropin | 2020 |
[What are the real purpose and scope of screening for aneuploidy?]
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; DNA; Down S | 2018 |
Second-trimester maternal serum screening for fetal Down syndrome: As a screening test for hemoglobin Bart's disease: A prospective population-based study.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin, beta Subunit, Human; Down Syndrome; Estriol; Fema | 2018 |
Management of ASC-US/HPV positive post-menopausal woman.
Topics: Aged; Atypical Squamous Cells of the Cervix; Biopsy; Cervix Uteri; Colposcopy; Disease Management; D | 2019 |
Correlation between spontaneous preterm birth and mid-trimester maternal serum estriol.
Topics: Adult; Biomarkers; Cohort Studies; Estriol; Female; Humans; Maternal Serum Screening Tests; Pregnanc | 2014 |
[The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
Topics: alpha-Fetoproteins; Biomarkers; Case-Control Studies; China; Chorionic Gonadotropin, beta Subunit, H | 2015 |
Novel chemiluminescent imaging microtiter plates for high-throughput detection of multiple serum biomarkers related to Down's syndrome via soybean peroxidase as label enzyme.
Topics: alpha-Fetoproteins; Antibodies, Immobilized; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human | 2015 |
Is salivary estriol detectable in very early pregnancy?
Topics: Adult; Estriol; Female; Humans; Immunoenzyme Techniques; Pilot Projects; Pregnancy; Pregnancy Trimes | 2017 |
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.
Topics: Abortion, Spontaneous; alpha-Fetoproteins; Biomarkers; Body Mass Index; Down Syndrome; Estriol; Fema | 2008 |
[Specificity of biochemical markers of pregnancy second trimester].
Topics: Adult; alpha-Fetoproteins; Biomarkers; Cross-Sectional Studies; Down Syndrome; Estriol; False Positi | 2007 |
Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Case-Control Studies; Chorionic Gonadotropin, beta Subunit, H | 2009 |
Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery.
Topics: Estriol; Female; Humans; Obstetric Labor, Premature; Pregnancy; Premature Birth; Progesterone; Risk | 2009 |
Analysis of nonderivatized steroids by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using C70 fullerene as matrix.
Topics: Adult; Estradiol; Estriol; Female; Fullerenes; Humans; Pregnancy; Progesterone; Sensitivity and Spec | 2009 |
Determination of endocrine-disrupting chemicals in the liquid and solid phases of activated sludge by solid phase extraction and gas chromatography-mass spectrometry.
Topics: Benzhydryl Compounds; China; Endocrine Disruptors; Estradiol; Estriol; Estrone; Ethinyl Estradiol; G | 2009 |
Measurement of nuchal translucency and the prenatal diagnosis of Down syndrome.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Early Diagnosis; Estriol; Female; | 2009 |
Development of competitive ELISAs for 17beta-estradiol and 17beta-estradiol +estrone+estriol using rabbit polyclonal antibodies.
Topics: Animals; Antibodies; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Estradiol; Estriol; Estrone | 2010 |
Biochemical and biophysical predictors of the response to the induction of labor in nulliparous postterm pregnancy.
Topics: Biomarkers; Body Mass Index; Cervical Length Measurement; Estradiol; Estriol; Female; Humans; Labor, | 2011 |
Self-assembly molecularly imprinted polymers of 17β-estradiol on the surface of magnetic nanoparticles for selective separation and detection of estrogenic hormones in feeds.
Topics: Animal Feed; Estradiol; Estriol; Magnetite Nanoparticles; Molecular Imprinting; Reproducibility of R | 2011 |
Analysis of estrogenic contaminants in river water using liquid chromatography coupled to ion trap based mass spectrometry.
Topics: Acetonitriles; Chromatography, Liquid; Diethylstilbestrol; Estradiol; Estriol; Estrogens; Estrone; E | 2002 |
A novel method for the detection of Down syndrome with the use of four serum markers.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol; False Positiv | 2002 |
Quantitative measurement of 17 beta-estradiol and estriol in river water by time-resolved fluoroimmunoassay.
Topics: Animals; Calibration; Cross Reactions; Estradiol; Estriol; Europium; Fluorescent Dyes; Fluoroimmunoa | 2002 |
Combined second-trimester biochemical and ultrasound screening for Down syndrome.
Topics: Adult; Amniocentesis; Biomarkers; Case-Control Studies; Chorionic Gonadotropin; Down Syndrome; Estri | 2002 |
Combinational use of antibody affinities in an immunoassay for extension of dynamic range and detection of multiple analytes.
Topics: Antibodies; Antibody Affinity; Antigen-Antibody Reactions; Estradiol; Estriol; Flow Cytometry; Immun | 2003 |
Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Topics: Algorithms; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Est | 2003 |
Incorporation of inhibin-A in second-trimester screening for Down syndrome.
Topics: Adult; alpha-Fetoproteins; Case-Control Studies; Chorionic Gonadotropin; Down Syndrome; Estriol; Fal | 2003 |
Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions.
Topics: Adult; Biomarkers; Cohort Studies; Estriol; Female; Fetal Diseases; Fetal Viability; Gestational Age | 2003 |
A SENSITIVE METHOD OF HIGH SPECIFICITY FOR DETERMINATION OF URINARY ESTROGENS.
Topics: Body Fluids; Chemistry Techniques, Analytical; Chromatography; Estradiol; Estriol; Estrogens; Estron | 1963 |
[Diagnostic methods for fetal malformations in the first half of pregnancy].
Topics: Abnormalities, Multiple; Adolescent; Adult; alpha-Fetoproteins; Chorionic Gonadotropin, beta Subunit | 2003 |
Steroid profiles using liquid chromatography-tandem mass spectrometry with atmospheric pressure photoionization source.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Chemistry Techniques, Analytical; Chromatography, Liq | 2004 |
[Combination of screening tests for fetal abnormalities in the first and second pregnancy trimesters].
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Congenital Abnormalities; Enzyme-Link | 2004 |
Abnormal multiple marker screens are associated with adverse perinatal outcomes in cases of intrauterine growth restriction.
Topics: alpha-Fetoproteins; Case-Control Studies; Estriol; Female; Fetal Growth Retardation; Humans; Logisti | 2004 |
A simple rapid assay of estrogens in pregnancy.
Topics: Biomarkers; Estriol; Estrogens; Female; Fetal Development; Gestational Age; Humans; Predictive Value | 1968 |
[A test system of prenatal screen for Down's syndrome].
Topics: Adult; alpha-Fetoproteins; Chromatography; Colloids; Computers; Down Syndrome; Equipment Failure Ana | 2005 |
Practical strategies in contingent sequential screening for Down syndrome.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; | 2005 |
Maternal serum screening of Palestinian women in the West Bank.
Topics: Adolescent; Adult; alpha-Fetoproteins; Bias; Chi-Square Distribution; Chorionic Gonadotropin; Chromo | 2005 |
Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Case-Control Studies; Chorionic Gonadotropin; Databases, Fact | 2006 |
The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Birth Weight; Body Weight; Cephalometry; Chorionic Gonadotrop | 2008 |
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Topics: Adult; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin, beta Subunit, Human; Diagnosis, Diffe | 2007 |
Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect.
Topics: Adolescent; Adult; Estradiol; Estriol; Estrone; Female; Gas Chromatography-Mass Spectrometry; Humans | 2008 |
Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Topics: Adolescent; Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Down Syndrome; Estriol | 2007 |
Establishment of an HPLC identification system for detection of counterfeit steroidal drugs.
Topics: Chromatography, High Pressure Liquid; Diethylstilbestrol; Estriol; Ethinyl Estradiol; Medroxyprogest | 2008 |
Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome | 1993 |
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol | 1994 |
Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Discriminant Analysis; Down Syndrome; Estrio | 1994 |
[Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study].
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol | 1993 |
The advantages of using triple-marker screening for chromosomal abnormalities.
Topics: Adolescent; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Di | 1995 |
MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs.
Topics: Adolescent; Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chorionic Gon | 1995 |
From biochemical to biophysical placental function tests in fetal surveillance.
Topics: Estriol; Female; Fetal Distress; Fetal Growth Retardation; Fetal Monitoring; Humans; Placental Funct | 1995 |
A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome | 1993 |
[Triple screening for trisomy 21: prospective results of 7039 assessments].
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Humans; Maternal Age; Pr | 1993 |
An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
Topics: Abortion, Therapeutic; Adult; alpha-Fetoproteins; Amniocentesis; Birth Rate; Chorionic Gonadotropin; | 1993 |
The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
Topics: Adult; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Estriol; Female; Humans; Middle Aged; Pr | 1996 |
Screening for Down's syndrome.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Humans; Inhibins; | 1996 |
Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Confidence Intervals; | 1994 |
Antepartum screening in the office-based practice: findings from the collaborative Ambulatory Research Network.
Topics: Adolescent; Adult; alpha-Fetoproteins; Ambulatory Care; Child; Chorionic Gonadotropin; Diabetes, Ges | 1996 |
Shared reaction in solid-phase immunoassay for estriol determination.
Topics: Antigen-Antibody Reactions; Enzyme-Linked Immunosorbent Assay; Estriol; Sensitivity and Specificity; | 1996 |
Enhancement of the sensitivity of a chemiluminescent immunoassay for estradiol based on hapten heterology.
Topics: Acridines; Antibodies, Monoclonal; Estradiol; Estriol; Female; Haptens; Humans; Immunoassay; Lumines | 1996 |
Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.
Topics: Adult; Case-Control Studies; Chorionic Gonadotropin; Embryonic and Fetal Development; Estriol; Femal | 1997 |
Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching high-performance liquid chromatography with fluorescence detection.
Topics: Chromatography, High Pressure Liquid; Estriol; Estrogens, Conjugated (USP); Female; Humans; Pregnanc | 1997 |
Significance of a false-positive trisomy 18 multiple-marker screening test.
Topics: Adult; alpha-Fetoproteins; Bias; Case-Control Studies; Chorionic Gonadotropin; Chromosomes, Human, P | 1997 |
Fetal gender impact on multiple-marker screening results.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Cohort Studies; Down Syndrome; Estriol; Fema | 1998 |
Bridge-heterologous chemiluminescence enzyme-linked immunosorbent assay of estriol 3-sulfate in pregnancy plasma.
Topics: Animals; Estriol; Female; Guinea Pigs; Luminescent Measurements; Magnetic Resonance Spectroscopy; Pr | 1998 |
New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
Topics: Algorithms; alpha-Fetoproteins; Amniocentesis; Biomarkers; Biometry; Chorionic Gonadotropin; Down Sy | 1998 |
A high-sensitivity alternative to "routine" genetic amniocentesis: multiple urinary analytes, nuchal thickness, and age.
Topics: Adult; Algorithms; Amniocentesis; Chorionic Gonadotropin, beta Subunit, Human; Down Syndrome; Estrio | 1999 |
Simultaneous determination of estriol and estriol 3-sulfate in serum by column-switching semi-micro high-performance liquid chromatography with ultraviolet and electrochemical detection.
Topics: Calibration; Chromatography, High Pressure Liquid; Electrochemistry; Estriol; Humans; Infant, Newbor | 1999 |
Urinary screening tests for fetal Down syndrome: I. Fresh beta-core fragment.
Topics: Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Creatinine; Down Syndrome; Drug Stability; | 1999 |
Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
Topics: Adolescent; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; False Positiv | 1999 |
Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subun | 1999 |
Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Case-Control Studies; Chorionic Gonadotropin; Down Syndrome; | 1999 |
The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
Topics: Adult; Age Factors; alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropi | 2000 |
Serial salivary estriol to detect an increased risk of preterm birth.
Topics: Adult; Biomarkers; Estriol; Female; Humans; Obstetric Labor, Premature; Predictive Value of Tests; P | 2000 |
Quantitative analysis of estrogens in human urine using gas chromatography/negative chemical ionisation mass spectrometry.
Topics: Benzoates; Calibration; Estradiol; Estriol; Estrogens; Estrone; Female; Gas Chromatography-Mass Spec | 2000 |
Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pa | 2000 |
Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Topics: Adolescent; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Computer | 2001 |
Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol; False Positive React | 2001 |
An immunoassay for small analytes with theoretical detection limits.
Topics: Antibodies, Monoclonal; Antigens; Estriol; Immunoassay; Kinetics; Microspheres; Sensitivity and Spec | 2001 |
A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Down Syndr | 2002 |
The comprehensive midtrimester test: high-sensitivity Down syndrome test.
Topics: Adult; Algorithms; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chorionic Gonadotropin | 2002 |
Non-radioactive assay of AFP, hCG, and uE3 from dried blood specimens: a low-cost alternative for maternal screening for trisomy 21.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Enzyme-Linked Immunosorbent Assay; Estrio | 1992 |
Prenatal screening for Down's syndrome with use of maternal serum markers.
Topics: Adolescent; Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chromosome | 1992 |
Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Evaluation Studies as Top | 1992 |
Radioimmunoassay for the determination of 2-methoxyestriol concentration in plasma of pregnant women.
Topics: Cross Reactions; Estriol; Female; Humans; Immune Sera; Pregnancy; Radioimmunoassay; Sensitivity and | 1992 |
Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
Topics: alpha-Fetoproteins; Biomarkers; Down Syndrome; Estriol; Fetal Diseases; Humans; Maternal Age; Predic | 1991 |
Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Humans; Mass Screening; | 1991 |
Rapid pregnancy urinary estrogen assays. A comparative study.
Topics: Chromatography, Gas; Estriol; Estrogens; Female; Fetal Diseases; Humans; Pregnancy; Reagent Kits, Di | 1971 |